Biosimilar pharmalogics are made from living organisms and offer a new and exciting way to treat breast cancer which can be less expensive, have fewer side effects and replicate the results of their chemical based counterparts.Dr. Chen earned her medical degree from the Perelman School of Medicine of the University of Pennsylvania and her Master’s of Public Health from the Harvard T.H. Chan School of Public Health.  She is a breast cancer medical oncologist and cancer epidemiologist. She works with the Nurses’ Health Study and has published extensively on nutritional, lifestyle, and hormonal f ..read more

We are getting more and more sophisticated in determining the types of breast cancer tumors and how they act in the body.  Dr. Knutson and his team at the Mayo clinic are working to discover how biologics play an important role with targeted therapies.Dr. Knutson is internationally recognized in the field of cancer immunology. His research focuses on the immunology and immunotherapy of breast and ovarian cancers, both the basic immunobiology and clinical translation, including clinical trials. His contributions to science include clinical development and testing of self-tumor antigen-specific ..read more

Getting back to feeling whole is a vital part of breast cancer recovery.  Having to lose one or more breasts during the treatment phase is not just physically taxing, it can scar mentally forever.  Dr. Fisher and her team work with patients to change that ..read more

Chemotherapy has been a gold standard for treatment of breast cancer and often over-treats women who may not need this aggressive treatment to treat their breast cancer.  Dr. Sparano serves as the study chair for the TAILORx clinical trial sponsored by National Cancer Institute, the first clinical trial integrating a mulitparameter gene expression assay in clinical decision making for adjuvant therapy with early stage ER-positive, HER2 negative breast cancer.  The results will eliminate the use of chemotherapy for thousands of women ..read more

When it's time for reconstructive surgery, there are so many options and opportunities it can be daunting for someone faced with this reality.  Dr. Potter specializes in natural reconstruction and in this episode talks about the options available today.  Board certified by the American Board of Plastic Surgery, she completed her undergraduate studies at Princeton University with a focus in Molecular Biology. She received her medical degree from the Emory University School of Medicine in Atlanta, Georgia. Following a Plastic Surgery Integrated Residency at the University of Texas Southwestern M ..read more

May 31st, 2018 Dawn Hershman is a tenured professor of medicine and epidemiology at Columbia University, where she leads their breast cancer program, and a nationally recognized expert in breast cancer treatment, prevention, and survivorship. She is also a Komen Scholar. In this episode, Hershman discusses the different struggles of survivorship and coping with the emotional effects of the treatment. After the treatment, survivors grapple with what has happened to them and the possibility of recurrence in the future. Many struggle with both the health and financial issues they are left with i ..read more

Dr. Yankeelov is a Computational Oncologist at the University of Texas where he and his team are working to solve the breast cancer equation. You won't believe how it works - solving for X has never been more exciting ..read more

Dr. Vineet Choudhry, MD is a general surgery specialist in Austin, TX and has been practicing for 10 years. He graduated from The Texas A&M University System Health Science Center College Of Medicine in 2003 and specializes in general surgery. Dr. Choudhry discusses clinical trials, specifically cryoblation treatment and the FROST clinical trial which freezes early stage breast cancer ..read more

As a breast imaging doctor, she interprets radiology images such as mammography (including 3D tomosynthesis and contrast-enhanced mammography), breast ultrasound, and breast MRI (including abbreviated MRI). She also does breast biopsies with imaging guidance.  She and her team have pioneered high-risk screening with MRI and offer personalized screening to women with average risk as well as those who may have a high-risk gene,such as BRCA1 or BRCA2.  Herresearch focuses on how best to use newer techniques to detect breast cancer early and to assess whether treatment is working ..read more

A ..read more